메뉴 건너뛰기
Bioanalysis
Volumn 4, Issue 12, 2012, Pages 1395-1397
Meeting the demands of regulatory requirements: The significance of ADME

(1)  Guttendorf, Robert a  

a NONE   (United States)
Author keywords

ADME; decision making; pharmacodynamics; pharmacokinetics; PK PD
Indexed keywords

DRUG ABSORPTION; DRUG APPROVAL; DRUG COST; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENCY; DRUG QUALITY; DRUG RESEARCH; GOOD LABORATORY PRACTICE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHYSICAL CHEMISTRY; REVIEW;
EID: 84863913817     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.135     Document Type: Review
Times cited : (4)
References (6)
  • 1
    • 0030886937 scopus 로고    scopus 로고
    • Managing the drug discovery development interface
    • Kennedy T. Managing the drug discovery/ development interface. Drug Discov. Today 2(10), 436-444 (1997
    • (1997) Drug Discov. Today , vol.2 , Issue.10 , pp. 436-444
    • Kennedy, T.1
  • 2
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rates
    • Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Disc. 3, 711-715 (2004
    • (2004) Nat. Rev. Drug Disc. , vol.3 , pp. 711-715
    • Kola, I.1    Landis, J.2
  • 3
    • 34548324706 scopus 로고    scopus 로고
    • The cost of biopharmaceutical R&D: Is biotech different
    • DiMasi JA, Grabowski HG. The cost of biopharmaceutical R&D: Is biotech different? Manag. Decision Econ. 28(4-5), 469-479 (2007
    • (2007) Manag Decision Econ. , vol.28 , Issue.4-5 , pp. 469-479
    • DiMasi, J.A.1    Grabowski, H.G.2
  • 4
    • 1542301706 scopus 로고    scopus 로고
    • Cost of developing a new drug increases to about $1.7 billion
    • 8 December
    • Landers P. Cost of developing a new drug increases to about $1.7 billion. The Wall Street Journal 8 December 2003.
    • (2003) Wall Street Journal
    • Landers, P.1
  • 5
    • 79551575056 scopus 로고    scopus 로고
    • Trial watch phase III and submission failures
    • Arrowsmith J. Trial watch; Phase III and submission failures. Nat. Rev. Drug Disc. 10(2), 87 (2011
    • (2011) Nat. Rev. Drug Disc. , vol.10 , Issue.2 , pp. 87
    • Arrowsmith, J.1
  • 6
    • 78549247082 scopus 로고    scopus 로고
    • Probabilistic risk analysis: Improving early drug development decision making
    • Mudd PN, Groenendaal H, Bush MA, Schmith VD. Probabilistic risk analysis: Improving early drug development decision making. Clin. Pharmacol. Ther. 88, 871-875 (2010
    • (2010) Clin. Pharmacol. Ther. , vol.88 , pp. 871-875
    • Mudd, P.N.1    Groenendaal, H.2    Bush, M.A.3    Schmith, V.D.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.